0.635
Xtant Medical Holdings Inc stock is traded at $0.635, with a volume of 46,394.
It is up +0.81% in the last 24 hours and up +0.79% over the past month.
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company also provides OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers various products to treat a range of spinal and sacroiliac conditions, including trauma, degeneration, deformity, and tumor. Xtant Medical Holdings, Inc. markets its products through direct sales, consignment agents, reseller distributors, private label distributors, and technology licensees. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
See More
Previous Close:
$0.6299
Open:
$0.6499
24h Volume:
46,394
Relative Volume:
0.62
Market Cap:
$82.75M
Revenue:
$78.46M
Net Income/Loss:
$2.75M
P/E Ratio:
63.50
EPS:
0.01
Net Cash Flow:
$-12.42M
1W Performance:
+0.52%
1M Performance:
+0.79%
6M Performance:
+13.39%
1Y Performance:
+0.79%
Xtant Medical Holdings Inc Stock (XTNT) Company Profile
Name
Xtant Medical Holdings Inc
Sector
Industry
Phone
406-388-0480
Address
664 Cruiser Lane, Belgrade, MT
Compare XTNT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XTNT
Xtant Medical Holdings Inc
|
0.635 | 84.68M | 78.46M | 2.75M | -12.42M | 0.01 |
![]()
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Xtant Medical Holdings Inc Stock (XTNT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-05-23 | Initiated | BTIG Research | Buy |
Nov-15-18 | Reiterated | Maxim Group | Buy |
Feb-14-18 | Reiterated | Maxim Group | Buy |
Xtant Medical Holdings Inc Stock (XTNT) Latest News
Xtant Medical Holdings Inc. Shows Early Signs of Technical StrengthJuly 2025 Highlights & Consistent Profit Focused Trading Strategies - newsyoung.net
Will earnings trigger a reversal in Xtant Medical Holdings Inc.Exit Point & Momentum Based Trading Ideas - Newser
Applying Elliott Wave Theory to Xtant Medical Holdings Inc.Trade Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Published on: 2025-08-19 23:29:58 - Newser
Custom strategy builders for tracking Xtant Medical Holdings Inc.Long Setup & Expert Approved Momentum Trade Ideas - Newser
Chart based exit strategy for Xtant Medical Holdings Inc.2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Will Xtant Medical Holdings Inc. benefit from macro trendsJuly 2025 Setups & Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Xtant Medical Holdings Inc.Weekly Volume Report & AI Driven Price Predictions - Newser
Will breakout in Xtant Medical Holdings Inc. lead to full recoveryWeekly Risk Summary & Precise Swing Trade Alerts - Newser
Analyzing net buyer seller activity in Xtant Medical Holdings Inc.Market Risk Analysis & Growth Oriented Trade Recommendations - Newser
Will Xtant Medical Holdings Inc. stock benefit from interest rate changesQuarterly Profit Summary & Weekly Watchlist of Top Performers - Newser
Can Xtant Medical Holdings Inc. rally from current levelsEarnings Summary Report & Fast Moving Trade Plans - Newser
Does Xtant Medical Holdings Inc. stock pay reliable dividends2025 Volatility Report & Weekly High Return Opportunities - Newser
Will Xtant Medical Holdings Inc. stock go up soonGap Up & Breakout Confirmation Trade Signals - Newser
Xtant Medical Holdings Inc. Consolidation Zone May Signal Accumulation2025 Growth vs Value & Low Drawdown Investment Strategies - beatles.ru
What makes Xtant Medical Holdings Inc. stock price move sharplyQuarterly Portfolio Review & Proven Capital Preservation Methods - Newser
Risk adjusted return profile for Xtant Medical Holdings Inc. analyzedTrade Performance Summary & Safe Swing Trade Setups - Newser
Will Xtant Medical Holdings Inc. Stock Benefit from AI and Green Energy TrendsJobs Report & High Return Trade Guides - Newser
Real time scanner hits for Xtant Medical Holdings Inc. explainedWeekly Trend Summary & AI Forecasted Stock Moves - Newser
How to use a screener to detect Xtant Medical Holdings Inc. breakouts - Newser
Will Xtant Medical Holdings Inc. outperform the marketJuly 2025 Retail & Advanced Technical Signal Analysis - Newser
Using portfolio simulators with Xtant Medical Holdings Inc. includedPortfolio Gains Report & Consistent Profit Trade Alerts - Newser
What Fibonacci levels say about RYET reboundQuarterly Trade Report & Step-by-Step Swing Trade Plans - Newser
Real time social sentiment graph for Xtant Medical Holdings Inc.Insider Buying & Stock Portfolio Risk Control - Newser
Backtesting results for Xtant Medical Holdings Inc. trading strategiesWeekly Investment Recap & Daily Stock Momentum Reports - Newser
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q2 2025 Earnings Call Transcript - Insider Monkey
Xtant Medical Holdings Inc (XTNT) Stock: A Year of Market Movement, Down and Up - investchronicle.com
Xtant Medical raises 2025 revenue outlook to $131M–$135M as it divests noncore assets and advances biologics platform - MSN
Xtant Medical Holdings Maintains Buy Rating on Strong Financials and Strategic Initiatives - AInvest
Xtant Medical Holdings Inc (XTNT) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Published on: 2025-08-13 13:25:29 - 선데이타임즈
Xtant Medical Reports Strong Q2 2025 Results - TipRanks
Xtant Medical to Attend the CG 45th Annual Growth Conference - Eastern Progress
Xtant Medical Q2 2025 Earnings Call Transcript - MarketBeat
Should you wait for a breakout in BARK Inc. Equity WarrantJuly 2025 Institutional & High Accuracy Buy Signal Tips - Newser
Is Xtant Medical Holdings Inc. stock overhyped or has real potentialGrowth Watchlist for Long Term Positioning - Newser
Xtant Medical Holdings Inc. At Critical Juncture — Bounce or BreakdownJuly 2025 Snapshot & Weekly Market Pulse Updates - sundaytimes.kr
Xtant Medical's Q2 2025 Earnings Call: Unpacking Contradictions in Revenue, Strategy, and Growth Drivers - AInvest
Transcript : Xtant Medical Holdings, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Xtant Medical Holdings Inc Stock (XTNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):